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Survival advantage in Asian American end-stage renal disease End-stage renal disease (ESRD) in Asian Americans
patients. is an important topic for many different reasons. Al-
Background. An earlier study documented a lower mortality though Asian Americans make up only 3.7% of therisk for end-stage renal disease (ESRD) patients in Japan com-
United States’ population, they are by far the fastestpared with the United States. We compared the mortality of
growing racial group [1]. Between the years 1980 andCaucasian (white) and Asian American dialysis patients in the
United States to evaluate whether Asian ancestry was associ- 1990, the Asian population in America doubled [2]. Fur-
ated with lower mortality in the United States. thermore, ESRD incidence rates per million population
Methods. The study sample from the U.S. Renal Data Sys- are higher for Asians than for Caucasian Americanstem census of ESRD patients treated in the United States
(whites), although they are not as high as for Africanincluded 84,192 white or Asian patients starting dialysis during
Americans (blacks) and Native Americans (354 casesMay 1995 to April 1997, of whom 18,435 died by April 30,
1997. Patient characteristics were described by race. Relative per million Asians vs. 199 cases per million whites) [3].
mortality risks (RRs) for Asian Americans relative to whites Previous studies comparing the survival of ESRD pa-
were analyzed by Cox proportional hazards regression models
tients in the United States and Japan found that Japaneseadjusting for characteristics and comorbidities. Population
patients had higher survival rates compared with U.S.death rates were derived from vital statistics for the United
States and Japan by age and sex. patients [4]. In a comparison of five-year renal replace-
Results. Adjusting for demographics, diabetes, comorbidi- ment therapy (RRT) survival rates of the United States
ties, and nutritional factors, the RR for Asian Americans was and Japan from 1982 to 1987, Held et al reported the0.75 (P 5 0.0001). Race-specific background population death
age- and diabetes-adjusted mortality relative risk (RR)rates accounted for over half of the race-related mortality dif-
for the Japanese patients to be 25% lower than for U.S.ference. For whites, mortality decreased as the body mass index
(BMI) increased. For Asians, the relationship between BMI patients (RR 5 0.75). The age-adjusted RR for nondia-
and survival was u-shaped. The ratio of Asian American/white betic Japanese was 0.71, and for diabetic Japanese, it
dialysis death rates and the ratio of Asian American/white
was 0.81. The results of this and a subsequent study havegeneral population death rates both varied by age in a similar
stimulated American nephrologists to evaluate theirpattern. The population death rates of Asian American and
Japanese were also similar. standards and practices [5].
Conclusion. Among dialysis patients, Asian Americans had The demographics and characteristics of the RRT pop-
a markedly lower adjusted RR than whites. The effect of BMI ulations in the two countries differed; the Japanese wereon survival differed by race. Compared with the respective
younger and less likely to be diabetic. However, thegeneral population, dialysis patients had the same relative in-
better outcomes were confirmed in each adult age groupcrease in death rates for both races. The difference in death
rates between the United States and Japan does not appear for both diabetic and nondiabetic patients. There were
to be primarily treatment related, but rather is related to back- also other difficulties in comparing the U.S. and Japanese
ground death rates.
RRT patients in that the rate of kidney transplantation
is much lower in Japan than in the United States [3].
1 See Editorial by Breyer-Lewis, p. 2528. However, the comparison of all ESRD patients should
have favored the United States because of the benefitsKey words: ESRD, mortality risk, race and renal disease, body mass
index, dialysis, renal replacement therapy, transplantation. of transplantation [4].
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are almost identical; however, there are differences). The shown in Table 1. For comorbid conditions, the response
of “yes” was counted as having the condition, and an-U.S. Renal Data System (USRDS) has reported that
different racial groups have different mortality risks for swers of “no,” “unknown,” or “cannot disclose” were
considered as not having the condition. Hemoglobin andESRD, and whites have the worst mortality [3]. Japan
is almost entirely comprised of people of Japanese or of hematocrit had more detailed methods for cleaning,
which considered the consistency of both values andother Asian descent. In the United States, the U.S. Cen-
sus Bureau statistics for 1996 includes whites (82.8% of clinical plausibility. The values for blood urea nitrogen
(BUN), serum creatinine, and glomerular filtration ratetotal U.S. population), blacks (12.7%), Native Ameri-
cans (0.9%), and Asians and Pacific Islanders (3.7%) (GFR) [7, 8] were obtained before the patient began
dialysis.[1]. Although the U.S. Asian population is a mixture of
different ethnic groups, a comparison of the mortality The body mass index (BMI) was computed as the
weight divided by the height squared in kg per meterrisk between white and Asian ESRD patients within the
United States may help to explain the difference between squared, and the patients were divided into five-unit BMI
groups (BMI group). The percentage of diabetic ESRDESRD mortality rates in the United States and Japan.
If the difference in ESRD mortality for the United States was then calculated for each BMI group by race.
The calculation of average dialysis dose (Kt/V) by raceversus Japanese were similar to that for U.S. white versus
U.S. Asian, the difference may be greatly accounted for group and the methods for survival analyses adjusting
for Kt/V are the same as used in waves 1, 3, and 4by the dissimilarities in the background populations and
not in the dialysis technique. If the U.S. Asians have of the USRDS Dialysis Morbidity and Mortality Study
(DMMS). The methodology for this more detailed studysurvival that is more similar to the U.S. whites than to
the Japanese, then the difference with Japan more likely of over 17,000 hemodialysis patients is described in the
USRDS 1998 Annual Data Report [3].would be a response to differences in dialysis practice
and technique, and not to patient population differences.
Statistical analysisThis study examines a national census of adult dialysis
patients who were incident between May 1995 and April The t-test was used to compare the mean values for
scaled variables, including age, weight, and hemoglobin1997, to examine the differences in patient population
characteristics and survival in U.S. whites and U.S. for whites and Asians. The chi-square test was used to
compare the Asian American versus white gender andAsians in an attempt to compare the adjusted survival
for these two groups. comorbidity distribution.
Cox proportional hazards regression models were
used to determine the mortality risk ratios of Asian pa-
METHODS
tients relative to white patients. These models were ad-
Data sources justed for different characteristics such as race, sex, dia-
betes as primary cause of ESRD, nutrition, laboratoryAll data for this study came from the USRDS Standard
Analysis Files [6]. This study was comprised of patients values, and comorbidities. The exact adjustments are
detailed in Table 3. To determine if the RR for racewho had a Medical Evidence Form signed by a physician
between May 1, 1995, and April 30, 1997, with a first varied by sex or diabetes, interaction variables were in-
cluded in the Cox model. Based on these results, thedialysis service date on or after January 31, 1995. Ex-
cluded from this study were patients who were younger Asian:white mortality risk ratios were calculated sepa-
rately for those with diabetes as the primary cause ofthan the age of 18, or those who died or were trans-
planted in the first 90 days of ESRD. Patients were fol- ESRD and for those with all other causes of ESRD.
Each race was divided into race-specific BMI quintiles,lowed until transplantation, loss to follow-up, or to the
end of the study on December 31, 1997. and the Asian:white risk ratios were also assessed by
BMI quintile. Other models determining Asian:whiteRace data came from two sources, the social security
files, which contain self-reported race (primary source), risk ratios were calculated by primary cause of ESRD
and then by geographic region. Another set of modelsand the Medical Evidence Form, which is filled out by
the dialysis center. Patients with a missing cause of that examined the RR of each race-specific BMI quintile
compared with the middle BMI quintile for whites wasESRD were excluded from the analyses. Only patients
who were classified as “white” or “Asian” were used created.
For the “Asian versus all others” comparison, the mor-in these analyses, unless otherwise specified. To allow
comparisons of Asians with all other patients, the racial tality risk ratios were calculated by the Cox proportional
hazards model, and the Asian risk ratio was calculatedgroups “Native American,” “black,” and “white” were
combined as “non-Asian.” relative to that of whites, blacks, and Native Americans
combined.Ranges of acceptable values for different patient char-
acteristics such as height, weight, and serum albumin are The death rates of the dialysis patients were calculated
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Table 1. Summary of patient characteristics by race
Mean or percent
Patient characteristics Acceptable range White Asian P value
Male % 55.9 50.4 0.001
Age at incidence .18 years 63.1 61.2 0.0001
Height 122–214 cm 168.1 161.2 0.0001
Weight 37.5–125 kg 71.9 61.6 0.0001
BMI kg/m2 25.5 23.6 0.0001
Serum albumin 0.8–6.0 g/dl 3.3 3.2 0.0001
Hematocrit 9–60% 28.6 27.8 0.0001
Hemoglobin 3–18 g/dl 9.6 9.3 0.0001
BUN 24–250 mg/dl 94.8 97.0 0.0001
Serum creatinine 3–33 mg/dl 8.1 9.1 0.0001
GFR Levey formula ml/min 7.1 6.2 0.0001
GFR Walser formula ml/min 5.6 3.6 0.0001
Primary cause of ESRDa % yes
Diabetes 44.0 46.5 0.001
Hypertension 23.6 22.1 0.025
Glomerulonephritis 11.6 16.4 0.001
Cystic kidney disease 3.3 1.9 0.001
Other urologic cause 2.5 1.5 0.001
Other cause 11.2 7.0 0.001
Unknown cause 4.0 4.7 0.015
Number of comorbidities 1.9 1.3 0.0001
Comorbidities % yes
AIDS 0.1 0.0 0.038
Cancer 5.7 2.1 0.001
Cardiac arrest 1.1 0.5 0.001
Cardiac dysrhythmia 6.7 3.6 0.001
Cerebrovascular accident 9.1 6.6 0.001
Congestive heart failure 35.1 25.8 0.001
COPD 8.5 2.8 0.001
Diabetes mellitus 50.9 51.2 0.674
HIV positive 0.1 0.0 0.064
Hypertension 69.8 68.0 0.011
Ischemic heart disease 27.4 15.9 0.001
Myocardial infarction 10.8 5.2 0.001
Peripheral vascular disease 17.0 7.2 0.001
Smoker 6.3 1.9 0.001
a Overall P value 5 0.0001
by determining the number of deaths that occurred dur- The Asians had a lower average count of comorbid
conditions (1.28) compared with whites (1.93, P 5ing the study and the number of total patient days alive.
The ratio of deaths per patient day was converted to 0.0001). This racial difference held true for patients with
diabetic ESRD and for those who had ESRD from differ-deaths per patient year to compare with the death rates
of the general population. SAS 6.12 was used for all ent causes, with diabetics having more comorbidities
descriptive and survival analyses. than nondiabetics. White diabetics had the highest aver-
age number of comorbid conditions (white diabetes
mellitus average 5 2.69, white non-diabetes mellitus av-
RESULTS erage 5 1.33, P 5 0.0001). Asian diabetics had fewer
Patient characteristics comorbidities than white diabetics but more than Asian
nondiabetics (Asian diabetes mellitus average 5 2.06,There were 125,962 patients in the original USRDS
Asian non-diabetes mellitus average 5 0.60, P 5 0.0001).data set whose start of ESRD was recorded during the
Asians had a lower percentage of every comorbid condi-two-year period. Excluding patients under 18 years of
tion except for diabetes (Table 1). Additionally, Asiansage and other races, there were 79,721 whites (94.7%)
had 5% more diabetes than whites at every BMI value,and 4471 Asians (5.3%). The demographics for the two
and both races had an increase of percentage of diabetesrace groups differed. In general, the whites were older,
with increasing BMI.taller, heavier, and had laboratory values that were con-
The distribution of primary causes of ESRD differedsidered to be more predictive of survival, as shown in
Table 1. overall between the races (P 5 0.001). Asians had more
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Table 2. Asian patient demographics by region and mortality risk ratio (RR) compared to whites (RR 5 1.0) in Cox model
adjusting for age, sex, diabetes by region
Percent Asian Percent of
Region (U.S. States) in region total Asians RR P value
1 (AL WA OR CA HI) 19.1 60.0 0.66 0.0001
2 (KY TN MS AL) 1.1 1.1 1.00 0.9987
3 (MT ID WY NV AK UT CO AZ NM) 2.7 2.7 0.73 0.2136
4 (TX OK AR LA) 1.6 3.3 0.76 0.2011
5 (NH ME VT MA RI CT) 1.9 1.9 0.80 0.4440
6 (WV VA MD DC VA NC SC GA FL) 4.2 13.4 0.89 0.1791
7 (MI WI IL IN OH) 1.7 5.3 0.84 0.2658
8 (ND SD NE KS MN IA MO) 1.7 2.2 0.56 0.0824
9 (NY NJ PA DE) 3.4 10.2 0.48 0.0001
10 Total U.S. 5.3 100.0 0.652 —
Table 3. Mortality risk ratios (RR) of Asians compared to whites
(RR 5 1.0) in Cox models by level of covariate adjustment
Covariates RR P value
Unadjusted 0.62 0.0001
Age 0.66 0.0001
Age, sex 0.66 0.0001
Age, sex, diab as primary cause of ESRDa 0.65 0.0001
Age, sex, diab, nutrition (albumin, creatinine) 0.70 0.0001
Age, sex, diab, nutrition, lab valuesb 0.69 0.0001
Age, sex, diab, comorbidity count 0.73 0.0001
Age, sex, diab, comorbiditiesc 0.73 0.0001
Age, sex, diab, nutrition, lab val, comorbidities 0.75 0.0001
By diabetes as primary cause of ESRD
(Asian-diabetes interaction, P value 5 0.0041)
DM only: age, sex 0.73 0.0001
No DM only: age, sex 0.58 0.0001
a Asian-male interaction, P value 5 0.9406
b “Lab values” include BUN, hematocrit, hemoglobin, pre-ESRD GFR
c “Comorbidities” includes the list of comorbid conditions shown in Table 1
Fig. 1. Mortality risk ratios (RR) for body mass index (BMI) quintiles
for whites (j) and Asians (d) on dialysis. The dialysis patients were
grouped as race-specific BMI quintiles, and the RRs are shown relativeglomerulonephirits as a primary cause of ESRD (16.4
to the middle BMI quintile for whites (RR 5 1.0). This model also
vs. 11.6% for whites) and less cystic kidney disease (1.9 adjusted for age, sex, and diabetes as a primary cause of ESRD. *P ,
0.05 for comparison to white middle BMI quintile; 1P , 0.05 forvs. 3.3% for whites), but in general, the figures appeared
comparison among Asians to Asian middle BMI quintile.very similar (Table 1).
The distribution of Asians starting ESRD therapy in
each of the nine census regions is shown in Table 2. The
majority of the Asian patients (83.6%) lived within three gesting similar race effects for males and females. The
regions: 1 (the Pacific West Coast, Hawaii, and Alaska), model that included age, sex, and diabetes was consid-
6 (the Southeast Atlantic Coast), and 9 (New York, New ered the “basic” model and served as a point of reference
Jersey, Pennsylvania, and Delaware), which corre- for other models.
sponded to the distributions of Asians in the general Nutrition. When pre-ESRD serum albumin and creat-
population. inine, indicators of nutritional state, were added to the
basic model, the risk ratio rose to 0.70 (P 5 0.0001).
Comparison of mortality risk When other laboratory values such as hemoglobin and
General. The unadjusted Asian:white mortality risk hematocrit were added to this model, the risk ratio basi-
ratio was 0.62 (P 5 0.0001), indicating that Asians had cally remained the same (RR 5 0.69, P 5 0.0001). BMI
a 38% lower mortality rate than whites (Table 3). When was not included in either model because BMI affected
adjusted for age and sex, the ratio increased to 0.66 survival probability very differently for the two race
(P 5 0.0001) and remained relatively unchanged when groups (Fig. 1).
adding diabetes as a primary cause of ESRD (RR 5 Comorbidities. When the demographics and diabetes
0.65, P 5 0.0001). There was no statistical evidence that model were adjusted for the comorbidity count, the risk
ratio was 0.73 (P 5 0.0001), with a risk ratio 17% higherthe Asian:white RR differed by sex (P 5 0.94), sug-
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Table 4. Mortality risk ratios for U.S. Asians in present study versusfor each additional comorbidity (RR 5 1.17, P 5 0.0001).
Japanese in Held et al’s study [4]
If the model was adjusted for each of the specific comor-
Present study Held studybidities, the risk ratio was the same (0.73, P 5 0.0001),
US Asian US Asian Japanesealthough each condition had a different associated risk.
vs. US vs. all vs. US allWhen the nutrition and laboratory values were added
White other races
to the model, the risk ratio basically remained the same
Unadjusted RR 0.62 0.73 0.63(0.75, P 5 0.0001).
Adjusted RR: age, sex, diabetes 0.65 0.71 0.75
Diabetes. To consider a separate effect of diabetes,
each racial group was divided into two groups by the
presence or absence of diabetes (DM) as a primary cause
of ESRD (DM or non-DM). In the main model, Asians that model was adjusted for nutritional parameters, the
had a survival advantage in both the DM and the non- RR was 0.64 (P 5 0.0001) rather than 0.70 (P 5 0.0001),
DM group. For DM, the Asian risk ratio was 0.73 (P 5 the RR for the same model without an adjustment for
0.0001), and for non-DM, it was 0.58 (P 5 0.0001). The weight (Table 3). When comorbidities were included in
Asian–diabetes interaction variable was significant (P 5 the model that adjusted for weight, the RR was 0.66
0.0001), meaning that the survival advantage that Asian (P 5 0.0001) as compared with 0.73 (P 5 0.0001), the
DM patients had over white DM patients was smaller RR for the same model without an adjustment for
than expected. weight. When the full model, which included demo-
graphics, diabetes, nutrition, other laboratory values, and
Body mass index comorbid conditions along with weight, the risk ratio
To standardize comparison groups further, the pa- was even higher (0.73, P 5 0.0001), as opposed to the
tients in each race were divided into quintiles by BMI risk ratio of that model without taking weight into ac-
so that each race had five equal race-specific BMI groups. count (RR 5 0.75, P 5 0.0001).
When the mortality risk for each BMI group was com-
Primary cause of end-stage renal diseasepared with the middle BMI quintile for whites, Asians
had the biggest advantage in the lowest three BMI The Asian to white mortality risk ratio varied slightly
groups, and the highest Asian BMI group had a mortality by primary cause of ESRD; however, it also had a sig-
risk not significantly different from that of the whites nificant advantage over whites among those with diabetic
(Fig. 1). ESRD (RR 5 0.73, P 5 0.0001), although this benefit
For the white patients, the risk ratios of BMI quintiles appeared smaller than for other causes of ESRD.
relative to the middle quintile for whites showed a consis-
Regiontent pattern of decreasing relative mortality risk as BMI
increased or stabilization above the middle quintile (Fig. It is also important to consider variations by geo-
1). For the RR for Asian patients compared with the graphic region in which the patients were dialyzed, be-
middle BMI quintile for whites, the results were dramati- cause the mortality risk for dialysis differed from region
cally different from the results for the whites, especially to region. Adjusting for race, age, sex, and diabetes as
in the two highest BMI quintiles (Fig. 1). For Asian primary causes of ESRD, the mortality risk of both
patients, the mortality risk was a u-shaped curve, with whites and Asians for each region compared with the
the lowest mortality risk at the middle BMI quintile. national risk (RR 5 1.0) ranged from 0.90 to 1.11. When
the whites and Asians were compared in each region,
Dose of dialysis there continued to be an Asian survival advantage in
In a special analysis of the more detailed DMMS data, most regions. Adjusting for age, sex, and diabetes, the
the Kt/V was considered for a sample of 234 Asian and risk ratios for Asians ranged from 0.48 to 0.89 in eight
4850 white hemodialysis patients. The mean Kt/V for of the nine regions and was equal (RR 5 1.0) in the
Asians was higher than for whites (1.30 vs. 1.23, P , least populated region (Table 2). The Asian-by-region
0.01). The mortality risk for Asians compared with interaction for each region showed no significant interac-
whites was 0.664 without an adjustment for Kt/V and tion (P values ranged from 0.13 to 0.92).
0.675 with an adjustment for Kt/V (P , 0.01 for each)
Asian versus all others comparison(abstract; Bloembergen et al, J Am Soc Nephrol, 9:205A,
1998). For an analysis examining all four main racial groups—
For the main data set, no dialysis dose measures were Native American, Asian, black, and white—patients
available. However, when the basic demographics and were categorized as “Asian” or “non-Asian,” with
diabetes model was adjusted for weight as an indirect Asians comprising 3.5% of the study population. When
correlate of dialysis dose, the Asians had a particularly the basic demographics and diabetes model compared
Asian versus non-Asian survival, Asians had a RR oflarge survival advantage (RR 5 0.58, P 5 0.0001). As
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Fig. 3. Relative death rates in the general population of Japanese and
U.S. Asians compared to U.S. all races. The age- and sex-specific death
rates for the general populations in Japan are shown relative to theFig. 2. Relative death rates of Asian Americans in the general popula-
corresponding death rates of the U.S. all races. Also, the age- and sex-tion (j) and Asian Americans on dialysis (d) compared with corre-
specific death rates of U.S. Asians in the general population were foundsponding white populations. The age-specific death rates of Asian
relative to the corresponding death rates of the U.S. general population.Americans in the general population are shown relative to the death
For example, in the 15 to 24 age group, Japanese males had 43% andrates of whites in the general population. Also, the age-specific death
U.S. Asian males had 64% of the U.S. all races males’ death rate.rates of Asian Americans are shown relative to death rates of whites
Symbols are: (j) Japanese males vs. U.S. males; (d) Japanese femaleson dialysis. For example, in the 15 to 24 age group, Asian Americans
vs. U.S. females; (h) U.S. Asian males vs. U.S. males; (s) U.S. Asianin the general population had 63% of the general-population whites’
females vs. U.S. females.death rate. Within the same age group, Asian American dialysis patients
had 85% of the white dialysis patients’ death rate. *The source for the
general population data is in [7].
The ratio of Asian to white death rates shows a similar
pattern by age group for the general population as it
0.71 (P 5 0.0001) compared with the other three racial
does for the dialysis population (Fig. 2). The Japanese
groups (Table 4). When nutrition, laboratory values, and general population also had a lower death rate than the
comorbid conditions were added to this model, the Asian United States as a whole [10]. Death rates for Japan and
survival advantage lessened but remained substantial for U.S. Asians are similar and are shown, relative to
and statistically significant (RR 5 0.80, P 5 0.0001). death rates for the entire U.S. population, in Figure 3.
Background population death rates
DISCUSSIONRace (Asian vs. white) was significantly related to
mortality (RR 5 0.65, P 5 0.0001 for the basic model) in The results of this study have shown that in the United
the dialysis population (chi-square 5 121). In a separate States, Asian dialysis patients have better survival than
analysis, the age-, race-, and gender-specific background white patients. This difference is seen when adjusting
population log death rates were also significant pre- for all the factors listed in Table 1. The significantly lower
dictors of dialysis mortality (x2 5 80). When both race mortality rate for Asian patients compared with white
and death rates were included in the model, the RR for patients varied only slightly (RR 5 0.75 to 0.62) ac-
race was similar (RR 5 0.66, P 5 0.0001), but the chi- cording to the level of adjustment. Thus, Asians had at
square statistic for race was reduced to 49. This indicated least a 25% lower mortality rate than corresponding
that population death rates explained more than half of white patients in the United States. This difference is
the variation in mortality (x2 5 72 5 121 2 49) that had due to factors other than those listed in Table 1.
been explained by race (x2 5 121). Note that a chi-square
Laboratory valuesof more than 4 relates to a P , 0.05.
When the basic model that adjusted for age, race, sex,
Death rates in the general population and diabetes also included serum albumin and creatinine,
Among dialysis patients, U.S. Asian patients had a which are markers for the nutritional state, the Asian
lower death rate than U.S. white patients in each of mortality risk ratio increased from 0.65 to 0.70 (P 5
seven age groups (Fig. 2). In the entire U.S. population, 0.0001; Table 3). This implies that Asians had better
U.S. Asians have a lower mortality than do U.S. whites nutrition than the whites. This is due to the fact that
(Fig. 2) in the same age groups, based on death rates when nutrition was taken into account, the Asian survival
advantage was lessened. The mean serum albumin forreported by the National Center for Health Statistics [9].
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the two racial groups was virtually the same (white mean than whites (78.7 cases per 1 million whites/year vs. 96.9
cases per 1 million Asians/year). Also, the comorbidityalbumin 3.3 mg/dl, and Asian 3.2 mg/dl), but the biggest
difference was in the mean pre-ESRD serum creatinine count for Asians, especially for cardiovascular diseases,
was much lower than for the whites. This may be ex-(white mean creatinine 8.1 mg/dl, Asian 9.1 mg/dl; Table
1). The serum creatinine effect was confounded by the plained by the fact that Asian diabetics are more likely
to have renal sequelae than whites and, perhaps, not asfact that it is both an indicator of muscle mass and also
of poor renal clearance. Therefore, it is unclear from likely to have cardiovascular consequences commonly
found in whites [15, 16]. Thus, ESRD may be an earlierthis model whether the Asians have a higher pre-ESRD
creatinine because they had better nutrition or because consequence in Asian diabetics and a later one in whites.
Alternatively, Asians may be otherwise healthier thanthey were started on dialysis at a later time. It is obvious,
however, that the better survival for Asians is not due to whites because their diabetes is better managed or less
advanced.starting dialysis early, that is, with better renal function.
Body mass index Dose of dialysis
Previous studies have found that the higher the doseWhen the effect of race-specific BMI quintile was ex-
amined, a higher BMI had a more protective effect for of dialysis that a patient receives, the better the survival
[17]. It is also generally true that patients with smallerwhites (Fig. 1). This confirms the findings by Leavey et
al of a lower relative mortality risk with higher BMIs volumes or weights tend to receive higher doses of dial-
ysis per treatment because dialysis use and length offor U.S. dialysis patients [11]. The race-specific effect of
BMI for Asian dialysis patients in this study, however, treatment are not sufficiently individualized (abstract;
Bloembergen et al, ibid). In the DMMS analyses of Asianshowed a different pattern with the lowest and highest
BMI groups at a higher mortality risk than the middle versus Caucasian dialysis patients, we found that on aver-
age, Asian patients had a higher Kt/V than Caucasians.BMI group (Fig. 1). This pattern was more consistent
with the mortality trends for BMI within the U.S. general However, this difference would account for only 5.5%
of the observed decrease in the Asian mortality rate andpopulation, although the u-shaped correlation of mortal-
ity with BMI is not nearly as dramatic as that for Asian had virtually no effect on the mortality risk comparison
in the DMMS [17]. Thus, the dose of dialysis can onlydialysis patients [12].
One may speculate that the lower mortality risk in the explain a small fraction of the mortality differences for
Asian and white dialysis patients in this study.upper BMI groups for white dialysis patients indicates
that the mortality risks associated with obesity were out-
Regionweighed by the superior nutrition in these patients. For
Asians, by contrast, the risk associated with obesity may The percentage of Asians in each region ranged
widely, and they were dialyzed in regions with good, bad,outweigh the nutritional benefits
and average survival when compared with the national
Body mass index and diabetes average. In fact, two of the three largest groups of Asians
were dialyzed in regions 6 and 9, both of which have aThe relative increase in mortality for Asian patients
with higher BMIs may stem from their greater risk of worse than the national average survival risk ratio (Table
2). Thus, it is unlikely that the Asian ESRD patientdiabetes associated with obesity compared with whites.
The “Thrifty Gene Hypothesis” conjectures that popula- survival advantage was accounted for by the fact that
they lived in regions with better than average outcomes.tions that have historically undergone repeated periods
of famine have developed mechanisms so that they are The range of Asian mortality risk ratios could be primar-
ily explained by the differences in regional mortalityextremely efficient in calorie storage [2]. When these
individuals are exposed to more affluent environments because the Asian–region interactions were not signifi-
cant.such as the Western diet, this adaptation becomes more
of a detriment because it results in higher levels of obe-
Asian versus all others comparisonssity and insulin resistance. Asian American adolescents
born in the United States were found to be more than A comparison of Asians versus the rest of the U.S.
population (Native Americans, blacks, and whites) wastwice as likely to be obese as the first-generation Asian
American population [13]. Although the incidence of useful for two reasons (Table 4). First, it served as a
sensitivity analysis. The results for Cox proportional haz-diabetes in Asian countries is quite low, especially in
rural areas [2], studies in England showed that Asian ards modeling for survival of Asian versus whites were
fairly consistent with results for Asian versus all others.immigrants develop diabetes at a much lower BMI than
do the whites [14]. Because the non-Asian group included blacks, who have
a lower dialysis mortality rate than whites, the AsianAn interesting set of findings is that Asians had a
nearly 25% higher incidence rate of ESRD from diabetes survival advantage was somewhat smaller in this compar-
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ison [3]. Second, the comparison is an excellent counter- U.S. total population, they were fairly similar, especially
part to the Japan versus U.S. risk ratios. The main differ- at the older age groups for both genders (Fig. 3). This
ence is that the Japanese were compared with the entire shows that U.S. Asians represented a reasonable study
United States, but the Asian Americans were compared substitute for the Japanese given the similar background
with non-Asian, that is, the Native Americans, blacks, death rates; therefore, by indirect comparison, much of
and whites. U.S. Asians, however, make up only 3.7% the difference in risk ratios of the U.S.–Japanese studies
of the U.S. population, so their effect on overall survival may be accounted for by an effect that was not related
was probably very minimal. Another difference was that to treatment. The underlying difference in the mortality
the study compared all ESRD patients, not only dialysis rates for the general populations may greatly account
patients. Because the Japanese data included very few for the difference in the mortality rates for the ESRD
transplant recipients, whereas the U.S. ESRD popula- populations.
tion had a higher transplant population, the Japanese
Conclusionssurvival advantage was smaller than a comparison re-
stricted to dialysis patients would have yielded. The mortality risk for Asian American dialysis pa-
The age- and diabetes-adjusted mortality risk for tients is 35 to 25% lower than that for whites. Race-
ESRD patients in Japan versus the United States was specific background death rates accounted for over half
reported as 0.75, and the risk for Asian American dialysis of the race-related mortality difference. This suggests
patients versus the rest of the U.S. dialysis patients was that unmeasured factors that differed between Asians
0.72. Asians who were treated in the United States are and whites deserve further study in both the general
of various ethnic backgrounds, making the comparison population and the ESRD population. Such factors may
a less than perfect counterpart to the Asians in Japan. include lifestyle and dietary components.
It does show by indirect comparison, however, that a Asians also have a higher risk of developing diabetes
similar mortality risk exists when comparing Japanese in the U.S. than they did in their native countries [2],
patients to Asian American ESRD patients rather than which puts them at risk for ESRD. To prevent this,
comparing Japanese to all of the United States. Asians may need to be monitored more carefully for
diabetes, especially at younger ages and all BMI levels.
Death rates in the general population
Prevention and early detection of diabetes in Asians may
One very important consideration when comparing be the most effective ways of reducing their mortality
the survival rates of white and Asian ESRD patients is from ESRD. Also, maintaining good nutrition and
that the survival rates of the general populations of the avoiding obesity for Asian patients will also promote
two races differed quite dramatically, especially with the their survival. Because the effect of BMI on survival was
older age groups, which included the majority of ESRD so different for the two races, this topic should be studied
patients [9]. The analyses that included race-specific further.
background death rates showed that background popula- The results from this study suggest that survival advan-
tion death rates explained more than half of the variation tages reported previously for ESRD patients treated in
in mortality that had been explained by race. When the Japan can be explained largely, if not completely, based
ratios of Asian to white death rates were compared for on differences in background death rates between the
both the general population and for the dialysis popula- Japanese and the non-Asian U.S. populations. Previous
tion, they followed a similar trend across age groups (Fig. concern that dialysis practices in the United States may
2). This would imply that the increase in deaths from be somehow inferior to those in Japan is not supported
dialysis above the general population’s death rate is ap- by this analysis.
proximately the same proportional amount for the two
races at each age group. In other words, having ESRD ACKNOWLEDGMENTS
posed the same increased risk of mortality for both races,
These data reported here have been supplied by the USRDS. Thegiven their background death rates. Thus, the difference
interpretation and reporting of these data are the responsibility of the
in population death rates could account for the differ- authors and in no way should be seen as an official policy or interpreta-
ence in dialysis survival rates between races. Therefore, tion of the U.S. government.
we speculate that factors that contribute to the general
Reprint requests to Friedrich K. Port, M.D., University of Michigan,population death rate such as genetics, diets, cultural KECC, 315 West Huron Street, Suite 240, Ann Arbor, Michigan 48103,
practices, and lifestyles were then responsible for much USA.
E-mail: portb@umich.eduof the disparity.
The death rates for Japan were also lower than the
REFERENCESdeath rates for U.S. whites and the United States in
general [9, 10]. When the death rates of the Japanese 1. U.S. Census Bureau: Resident Population of the United States:
Estimates, by Sex, Race, and Hispanic Origin, with Median Age,and of the U.S. Asians were compared relative to the
Wong et al: Survival in Asian American ESRD patients 2523
May 29, 1998. http://www.census.gov/population/estimates/nation/ States in Monthly Vital Statistics Report 46:1(S). Hyattsville, Na-
tional Center for Health Statistics, 1996, pp 10–11infile3-1.txt.html
2. Fujimoto W: Diabetes in Asian and Pacific Islander Americans, 10. World Health Organization: World Health Statistics Annual
1995. Geneva, World Health Organization, 1996, p B718in Diabetes in America (2nd ed), Bethesda, The National Institutes
of Health, National Institute of Diabetes and Digestive and Kidney 11. Leavey SF, Strawderman RL, Jones CA, Port FK, Held PJ:
Simple nutritional indicators as independent predictors of mortal-Diseases, 1995, pp 661–681
3. U.S. Renal Data System: USRDS 1998 Annual Data Report. ity in hemodialysis patients. Am J Kidney Dis 31:997–1006, 1998
12. Durazo-Arvisy RA, McGee DL, Cooper RS, Liao Y, Luke A:Bethesda, The National Institutes of Health, the National Institute
of Diabetes and Digestive and Kidney Diseases, 1998 Mortality and optimal body mass index in a sample of the US
population. Am J Epidemiol 147:739–749, 19984. Held PJ, Brunner F, Odaka M, Garcia JR, Port FK, Gaylin
DS: Five-year survival for end-stage renal disease patients in the 13. Popkin BM, Udry JR: Adolescent obesity increase significantly in
second and third generation U.S. immigrants: National longitudinalUnited States, Europe, and Japan, 1982 to 1987. Am J Kidney Dis
15:451–457, 1990 study of adolescent health. J Nutr 128:701–706, 1998
14. Simmons D, Williams DR, Powell MJ: Prevalence of diabetes in5. Held PJ, Akiba T, Stearns NS, Marumo F, Turenne MN, Maeda
K, Port FK: Survival of middle-aged dialysis patients in Japan and a predominantly Asian community: Preliminary findings of the
Coventry diabetes study. BMJ 298:18–21, 1989the US, 1988-89, in Death on Hemodialysis, edited by Friedman
EA, Dordrecht, Kluwer Academic Publishers, 1994, pp 13–23 15. Burden AC, McNally PG, Feehally J, Walls J: Increased inci-
dence of end-stage renal failure secondary to diabetes mellitus in6. U.S. Renal Data System: Researcher’s Guide to the USRDS Data-
base. Bethesda, The National Institutes of Health, National Insti- Asian ethnic groups in the United Kingdom. Diabet Med 9:641–645,
1992tute of Diabetes and Digestive and Kidney Diseases, 1998
7. Levey AS, Bosch JP, Lewis JA, Greene T, Rogers N, Roth D: 16. Samamta A, Burden AC, Jagger C: A comparison of the clinical
features and vascular complications of diabetes between migrantA more accurate method to estimate glomerular filtration rate
from serum creatinine: A new prediction equation. Ann Intern Asians and Caucasians in Leicester, U.K. Diabetes Res Clin Pract
14:205–213, 1991Med 130:461–470, 1999
8. Walser M, Drew HH, Guldan J: Prediction of glomerular filtra- 17. Held PJ, Port FK, Wolfe RA, Stannard DC, Carroll CE,
Daugirdas JT, Bloembergen WE, Greer JW, Hakim RM: Thetion rate from serum creatinine concentration in advanced chronic
renal failure. Kidney Int 44:1145–1148, 1993 dose of hemodialysis and patient mortality. Kidney Int 50:550–556,
19969. Hoyert D, Kung H: Asian or Pacific Islander Mortality Selected
